Early Immune Responses to Vaccination - A Substudy to HVTN 205

Completed

Conditions studied: HIV Infections

In brief

HVTN 908 is a sub study of the HIV vaccine trial, HVTN 205. The purpose of this sub study is to better understand how a person's immune system responds to vaccines, particularly HIV vaccines. More specifically, researchers will determine whether early responses in the immune system help predict strong and long-lasting immunity.

Key facts

Study ID
NCT00908323
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
47
Starts
2009-07-01
Expected to finish
2012-07-01
Last updated by the study team
2021-10-15

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.